In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

J&J buys Cordis, builds force in vascular disease management

Executive Summary

Johnson & Johnson made a $1.6 billion hostile tender offer for Cordis (angiography and other coronary devices) at $100/share cash. J&J says it will cancel the takeover in favor of a negotiated stock-for-stock merger worth $1.7bn if Cordis accepts.
Deal Industry
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition

Related Companies

UsernamePublicRestriction

Register